5.3 systematic review of polypharmacy studies in child and adolescent psychiatry: focus on adhd
The goals of this session are to conduct a systematic review of psychiatric medication combination studies for youth with ADHD and to examine the evidence that supports the use of more than one concurrent psychotropic medication. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Megan Baker, Robert J. Hilt Source Type: research

5.4 systematic review of polypharmacy studies in child and adolescent psychiatry: the nos group
The research team was interested in documenting the extent of the research to date, looking at combination trials or one plus one medication studies. We were particularly interested in whether the evidence base supported current clinical practice in which children and adolescents are frequently prescribed more than one psychotropic medication concurrently. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Christopher Bellonci Source Type: research

Understanding and predicting psychopathology in young people exposed to trauma
Traumas present substantial challenges in clinical practice and public health, such as the assessment and treatment of psychopathology in trauma-exposed individuals and planning of service provision. To improve assessment and treatment in trauma-exposed young people, it is important to provide a clear understanding of the epidemiology and structure of psychopathology in this population and to improve individualized risk prediction. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Andrea Danese, Judith A. Cohen Tags: Symposium 6 Source Type: research

6.1 trauma and ptsd in a representative cohort of british young people
We described the prevalence and clinical features of trauma exposure and PTSD in a representative cohort of British young people to inform clinical assessment, treatment, and service planning. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Stephanie J. Lewis Source Type: research

6.2 symptom network architecture in youth with and without interpersonal violence exposure
There is growing evidence to suggest that interpersonal violence (IPV) exposure in youth instantiates a unique ecophenotype characterized by a more severe and comorbid constellation of psychopathology symptoms. The current work uses a network methodology to determine whether IPV exposure biases typical manifestation of mental illness symptoms in youth. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Ryan Herringa Source Type: research

6.3 identification of traumatic stress and suicidality among abused youth
Children who disclose abuse are often evaluated at Children ’s Advocacy Centers (CACs), with more than 300,000 evaluations every year. CAC evaluations consist of a forensic interview and/or medical evaluation. Recently, the National Children’s Alliance recommended that CACs detect and refer for traumatic stress. However, little guidance exists about effe ctive strategies to detect, assess, and refer children evaluated at CACs. We developed and piloted a standard trauma screening to evaluate risk and enhance referral for traumatic stress in CACs. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Brooks Keeshin Source Type: research

6.4 predicting ptsd in trauma-exposed young people
Previous research has identified risk factors for PTSD and found that groups of trauma-exposed young people with a risk factor are, on average, more likely to develop PTSD than groups of trauma-exposed young people without such risk factors. However, single risk factors cannot be used to accurately predict PTSD because of heterogeneity within groups. In addition, previous multivariate prediction models have not been validated in external samples, with the risk of overfitting and limited practical use. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Andrea Danese Source Type: research

From constructs to circuits: how can the research domain criteria (rdoc) framework inform our clinical practice?
This Symposium will explore how the research domain criteria (RDoC) framework informs our understanding of child psychopathology. RDOC integrates many levels of information (from genomics and circuits to behavior and self-reports) to explore basic dimensions of functioning that span the full range of human behavior from normal to abnormal. Progress is being made in understanding the levels of information that are accessible from this line of inquiry. However, clinicians continue to rely on categorical diagnostic systems to evaluate and develop treatment plans for children and adolescents with mental health disorders. (Sour...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: David Cochran, Antonio Hardan, Uma Vaidyanathan Tags: Symposium 7 Source Type: research

7.1 linking research domain criteria (rdoc) to developmental psychopathology: self-regulation as an intervention target in early childhood
Despite almost decade-long efforts since the initiation of the Research Domain Criteria (RDoC) project, integrating RDoC into developmental psychopathology, especially the application of RDoC to early childhood, has been understudied. Identifying RDoC constructs in early childhood is essential for understanding etiological pathways of psychopathology. Our central goals were to identify and establish RDoC constructs in early childhood across different functional domains and to examine how they relate to typical versus atypical symptom trajectories between ages 3 and 10 years. (Source: Journal of the American Academy of Chil...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Ka Ip, Sheryl Olson Source Type: research

7.2 the circuit-level analysis of social cognition processes using structural and functional neuroimaging in asd
One of the primary units of analysis of the Research Domain Criteria (RDoC) framework is the circuit-level description of the various domains of function. Our goal was to demonstrate the use of resting-state functional connectivity (rsFC) and diffusion tensor imaging (DTI) in ASD to better understand the neurocircuitry involved in the social cognition domain. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: David Cochran, Steven Hodge, Jean A. Frazier, David Kennedy Source Type: research

7.3 cognitive control development in asd: can research domain criteria (rdoc) help us to better understand behavioral phenotypes and pathophysiology?
The objective of this presentation is to initiate a Research Domain Criteria (RDoC)-oriented examination of cognitive control (CC) in ASD by: 1) determining the proportion of those with ASD who are impaired in CC compared with those with typical development (TYP); and 2) investigating the neural correlates of CC in ASD compared with those with TYP with better and poorer task performance. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Marjorie Solomon, Marie K. Krug, Cory Coleman, Matthew V. Elliott, Jeremy Hogeveen, Rachel Wulff, Tara Niendam, J. Daniel Ragland Source Type: research

7.4 mapping the research domain criteria (rdoc) social communication sub-constructs to the social responsiveness scale
The objective of this presentation is to derive estimations of the Research Domain Criteria (RDoC) social constructs from the Social Responsiveness Scale (SRS) and to explore their utility in capturing individual patterns of strengths and weaknesses across the identified factors in a large, clinically diverse sample group. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Antonio Hardan, Mirko Uljarevic, Thomas William Frazier, Jennifer M. Phillips, Booil Jo, Sandy Littlefield Source Type: research

Meditative interventions in child and adolescent psychiatry
The value of meditation as a clinical tool is now well-established. However, many clinicians are unaware of the extensive evidence base supporting the use of meditative interventions across a broad range of mental health disorders. The purpose of this Symposium is to report on the results of several recent clinical trials evaluating meditative interventions in child and adolescent psychiatry. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: David C. Saunders, James J. Hudziak Tags: Symposium 8 Source Type: research

8.1 three randomized experiments on the  longitudinal effects of the transcendental meditation technique on cognition
There are 3 categories of meditation: focused attention, open monitoring, and automatic self-transcending (AST) —which differ in their effects on the brain. Transcendental meditation (TM) technique is AST and increases alpha1 (8–10 Hz) EEG power, and coherence and default mode activity correlated with improved cognitive performance. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: David Orme-Johnson Source Type: research

8.2 effect of transcendental meditation on arrests and school attendance in adolescent high school students: a randomized controlled trial
Growing evidence suggests that constant exposure to environmental stressors, such as an abusive household or a dangerous neighborhood, can contribute to what is known as “toxic” or “chronic” stress. For adolescents with developing brains, these stressors can cause lasting psychological and physiological impairments, particularly in areas of the brain that influence learning, behavior, and mental health. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Chris Busch Source Type: research

8.3 mindfulness-based adhd treatment for children: a pilot feasibility study
ADHD is a neurodevelopmental disorder associated with a myriad of adverse outcomes. Medication is known to be effective but is limited by side effects. Mindfulness improves attention in healthy adults, as well as adults with ADHD, and 2 small studies in teenagers with ADHD have shown preliminary evidence of efficacy. To our knowledge, however, there are no standardized mindfulness interventions for children with ADHD, nor has it been studied in a rigorous research setting in children. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: David C. Saunders Source Type: research

New findings from the multimodal treatment of adhd (mta) study follow-up
This Symposium presents new findings from the Multimodal Treatment Study of ADHD (MTA) 16-year prospective follow-up study. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Lily Hechtman, Steven R. Pliszka Tags: Symposium 9 Source Type: research

9.1 maternal personality traits moderate adhd treatment response in the multimodal treatment study of adhd (mta)
The goal of this session is to evaluate the moderating effect of maternal personality traits (neuroticism, conscientiousness) on treatment response in the Multimodal Treatment Study of ADHD (MTA). (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Guillermo Perez Algorta Source Type: research

9.2 patterns and predictors of stimulant medication use from childhood to adulthood in the prospective long-term follow-up of the multimodal treatment study of adhd (mta)
Most children diagnosed with ADHD are treated with stimulant medication. The AACAP Practice Parameter for the assessment and treatment of ADHD (recommendation number 12) advises treatment for as long as symptoms persist, but information on duration of medication use (treatment as usual in clinical practices) is limited. The main objective is to use the data from long-term follow-up of the MTA to address this important gap in the literature. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: James M. Swanson Source Type: research

9.3 adolescent predictors of adult outcome in adhd: results from the multimodal treatment study of adhd (mta)
The goal of this session is to explore the importance of adolescent functioning in predicting adult functioning in participants with and without ADHD. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Lily Hechtman Source Type: research

Pediatric trichotillomania: an update on screening, genetics, and treatment
This Symposium will cover recent research on trichotillomania (also known as hair-pulling disorder), highlighting new developments relevant to the clinical practice of child and adolescent psychiatry. Presentations will review data on clinical screening tools, genetic studies, behavioral therapies, and pharmacological treatments. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Michael H. Bloch, Emily Olfson, S. Evelyn Stewart Tags: Symposium 10 Source Type: research

10.1 genetic findings in trichotillomania
Trichotillomania, or hair-pulling disorder, is a difficult-to-treat impairing condition with onset typically in early adolescence. The goal of this presentation is to provide an overview of previous research on the genetics of trichotillomania and to discuss new results from a whole-exome sequencing study. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Emily Olfson Source Type: research

10.2 habit reversal training for hair pulling disorder
Hair-pulling behaviors are relatively common among youth with mental health disorders and can result in significant distress and impairment. Habit reversal training (HRT) has demonstrated efficacy for reducing hair-pulling behaviors across several randomized, controlled trials. This has led experts to recommend HRT as a first-line treatment for youth with hair-pulling disorder (formerly called trichotillomania). This presentation describes the empirical support of HRT and delves into the implementation of its clinical components. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Joseph McGuire Source Type: research

10.3 pharmacological treatment of trichotillomania
Trichotillomania, or hair-pulling disorder, is a functionally impairing, often overlooked disorder, with no US FDA-approved medications for its treatment. Several pharmacological studies, however, have offered promise for those with trichotillomania, but the ability of clinical trials to detect beneficial effects of active treatment in trichotillomania has been hampered by a lack of understanding of the possible subtypes of trichotillomania and the unusually high placebo response rate. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Jon E. Grant Source Type: research

10.4 evaluation and assessment of trichotillomania across the lifespan
Trichotillomania (TTM, also known as hair pulling disorder) is a mental health disorder in which patients pull their own hair, leading to noticeable hair loss. It is a relatively common mental health disorder, as studies suggest that between 0.6 percent and 1 percent of the general population meet criteria for TTM, with females being more likely to be affected. Although trichotillomania has an onset in childhood (typically ages 11 –13 years of age), it is most commonly studied in adulthood. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Michael H. Bloch, Luis C. Farhat Source Type: research

Research symposium: advances in the genetics of neurodevelopmental disorders: translating findings to the clinic
The goal of the 2019 Research Symposium is to highlight advances in the genetics of ASDs and to provide a roadmap for translation of this information into clinical practice. The presenters will highlight the potential for improved treatments for neurodevelopmental disorders based on current advances in genetics. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Ellen J. Hoffman, David Cochran Tags: Symposium 11 Source Type: research

11.1 the revolution has begun: asd, genomics, and the advancing science of neurodevelopmental disorders
The past decade has witnessed the emergence of reliable and systematic gene discovery in ASDs. Over the past 5 years, dramatic progress has been made in identifying rare, large-effect mutations that contribute to approximately 20 percent of cases in the clinic. More recently, the first common alleles for ASD risk have also been identified, contributing very small individual effects but across a greater percentage of the population. These molecular clues offer a foothold into the pathophysiology of ASD and, consequently, offer a number of potential paths from the gene to therapeutics. (Source: Journal of the American Academ...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Matthew State Source Type: research

11.2 harnessing an asd genomic revolution in the here and now: personalized medicine, risk-based counseling, and what to do about polygenic risk
A large share of the population-attributable risk of ASD is traceable to complex polygenic inheritance. The ability to clinically distinguish inherited from noninherited forms of ASD has significant public health implications and underscores the opportunity to complement the discovery of gene-based therapeutic targets with that of: 1) early phenotypic targets that index polygenic liability; and 2) common “comorbidities” that exacerbate the severity of impairment in ASD. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: John N. Constantino Source Type: research

Complementary and integrative treatments for asd and adhd: selected recent research
The goals of this presentation are to review recent RCTs and their follow-ups (FU) of complementary/alternative treatments for ADHD and ASD and to evaluate their scientific basis. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: L. Eugene Arnold, James T. McCracken Tags: Symposium 12 Source Type: research

12.1 essential oils for improving quality of life and anxiety in asd
The goals of this session are to evaluate the feasibility of a larger multisite trial of essential oils for improving the quality of life (QOL) and anxiety in children with ASD and to collect preliminary data on the benefits and tolerability of essential oils. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Jill A. Hollway, L. Eugene Arnold, Xueliang Pan, Taylor Wong, Cheryl Li, Craig E. Williams, Robert R. Rice Source Type: research

12.2 folinic acid improves verbal ability in children with asd, language impairment, and folate receptor blocking antibodies
The goal of this presentation is to determine whether folinic acid can improve verbal ability in ASD. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Deborah R. Simkin Source Type: research

12.3 one-year follow-up of double-blind rct of neurofeedback for adhd
The goal of this session is to determine whether neurofeedback (NF) has a delayed specific benefit for ADHD beyond a nonspecific benefit, such as placebo response and a benefit of 30+ sessions, with coaching and encouragement to focus on a screen. Unblinded RCTs have shown encouraging results, but small blinded, flawed RCTs have not. Some of those have shown delayed benefit in follow-up (FU) reports. Despite wide variation in its quality, NF has the potential to be an alternative or adjunct to medication with a more enduring effect. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: L. Eugene Arnold, Roger DeBeus, Cynthia Kerson, Vincent J. Monastra, Robert R. Rice, Justin A. Barterian, Xueliang Pan, Neurofeedback Collaborative Group Source Type: research

12.4 one-year follow-up and microbiota analysis of double-blind randomized controlled trial of micronutrients for adhd
The goal of this session is to determine whether treatment at 1-year follow-up of a 12-week randomized placebo-controlled trial of micronutrients (vitamins-minerals) for ADHD was associated with differential outcomes and if treatment during the randomized, controlled trial affected gut microbiota. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Julia Rucklidge, Matthew Eggleston, Kathryn Darling Source Type: research

Digital health: games, applications, and smartphones for engagement and adherence to care
Digital technologies play an increasingly significant role in the lives of youth, because devices communicate information, reinforce cultural norms, and influence personal identity and behaviors. Additionally, gaming on phones is popular, and its appeal creates a unique opportunity to deliver health education during leisure time and outside of the clinic. Compelling interactive games can expose players to essential health-related content thousands of times, give players unlimited opportunities to rehearse new skills, and provide personalized feedback on health choices made within the game. (Source: Journal of the American ...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Larry K. Brown Tags: Symposium 13 Source Type: research

13.1 who is helped by an iphone game to improve medication adherence?
This study examines the preliminary moderating effects of symptoms of mental illness, social support, substance use, and gaming history on the impact of an iPhone game for ART adherence among YLWH in Jackson, Mississippi. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Larry K. Brown Source Type: research

13.2 smartphone and tablet interventions for underserved and at-risk youth
The goal of this session is to present results from 2 research studies that use digital health tools for underserved and at-risk youth. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Niranjan S. Karnik Source Type: research

13.3 intervention development and design: determining elements of mobile health intervention to promote cannabis cessation among adolescents with cannabis use disorders
The rates of cannabis use continue to increase among adolescents; however, current interventions have modest effects and high rates of relapse after treatment. There is increasing evidence for the efficacy of mobile technology-based interventions for adults with substance use disorders but a limited study of this technology in adolescent substance users. Using a user-centered design approach, our goal is to elucidate elements of an app-based adjunctive intervention for cannabis cessation that resonates with adolescent cannabis users. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Kara Bagot Source Type: research

13.4 acceptability and feasibility of mobile devices for health (mhealth) platforms to increase engagement and retention among commercially sexually exploited youth
Mobile devices for health (mHealth) have been demonstrated as efficacious, low-cost ways of reaching underserved populations to engage them in and/or deliver quality care. The goals of the current study were to: 1) gauge the feasibility and acceptability of an mHealth tool for justice-involved youth with histories of commercial sexual exploitation (CSE); 2) understand if and how youth currently use mobile phones for health-related information; and 3) identify potential gaps in treatment adherence that could be mitigated by mHealth to increase engagement. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Eraka Bath Source Type: research

13.5 the wonder of it all: early childhood digital health
We will: 1) describe the WonderLab, a digital health initiative within the New York University Langone Health Department of Child and Adolescent Psychiatry; 2) introduce When to Wonder: Picky Eating, which is the WonderLab ’s first early childhood mental health digital study; and 3) present preliminary data from this study. Our first objective is to demonstrate how smartphone-based tools developed to assess children in their homes and the use of advanced data analytics can transform how, when, and where we assess yo ung children’s development and mental health. (Source: Journal of the American Academy of Child ...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Helen L. Egger, Timothy L. Verduin, Steven Robinson, Rachel Lebwohl, Cheryl R. Stein, Kyle A. McGregor, Chenyue Zhao, Katherine Driscoll, Devin Mann, Julia Black Source Type: research

Federal efforts to improve mental health and substance use outcomes for youth
Youth mental health and substance use problems are growing public health concerns. In 2017, the CDC reported that suicide was ranked as  the second leading cause of death among youth ages 10 to 24 years. From 2015 to 2016, death rates by drug overdose increased by 28 percent among youth ages 15–24 years. Federally funded initiatives aim to decrease rates of death by suicide and substance use. This presentation will describe init iatives by the CDC, NIMH, NIDA, and SAMHSA to reduce suicide and overdose. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Maryland Pao Tags: Symposium 14 Source Type: research

14.1 research opportunities at nida
This presentation will highlight NIDA ’s research initiatives on all aspects of substance use/misuse and substance use disorders as they pertain to youth. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Geetha Subramaniam Source Type: research

14.2 epidemiology of youth suicide and a public health approach to prevention
Suicide among youth aged 10 –24 years is on the rise in the United States, and suicide is a leading cause of death in this population. Multiple contributing circumstances are associated with these deaths. Suicide deaths are only part of a much larger problem encompassing suicide ideation, plans, and attempts. This presentati on will describe the epidemiology of the broad youth suicide problem, as well as a public health approach to prevention. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Deborah Stone Source Type: research

14.3 screening for suicide risk in medical settings: adapting research to real-world implementation
This presentation will discuss how federal research that developed a suicide risk-screening tool for the pediatric emergency department was tested and implemented in other medical settings to leverage health care providers as partners in combating the public health crisis of youth suicide. Examples showing the feasibility of universal suicide risk screening for youth will be described. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Lisa M. Horowitz Source Type: research

14.4 efforts to promote children's mental health at samhsa
This presentation will address activities at the federal level in the area of school mental health. From the vantage point of a federal employee, the speaker will describe lessons learned from cross-agency and public-private partnerships working to promote school mental health. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Justine Larson Source Type: research

14.5 improving outcomes through systems of care: advancing partnerships, improving lives
The goals of this session are as follows: 1) to learn about SAMHSA initiatives for children, youth, and young adults who experience serious emotional disturbance (SED) or serious mental illness (SMI); 2) to increase knowledge about the systems-of-care approach, including strategies to engage and empower youth and families, the importance of cultural and linguistic competence, and current trends in evidence-based and evidence-informed practice; 3) to learn about the efforts to improve cross-agency collaboration and increase integration of mental health care across child-serving sectors to better serve children, youth, and y...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Gary Blau Source Type: research

Eeg biomarkers of treatment response in developmental disorders
Biomarkers represent an objective measure of biological processes, pathology, or biological response to treatment and provide an appealing alternative to observation or report of complex behaviors associated with neurodevelopmental disorders. However, biomarkers are not currently well-integrated into the mental health care practice. This Symposium will provide 4 examples of research efforts to advance the use of biomarkers in the measurement of response to therapeutic interventions for neurodevelopmental disorders. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Susan Faja, James T. McCracken Tags: Symposium 15 Source Type: research

15.1 trigeminal nerve stimulation for adhd: correlates and predictors of treatment response
Trigeminal nerve stimulation (TNS) is a noninvasive neuromodulation method with minimal risk that has shown benefits for ADHD in a double-blind, sham-controlled trial, with an estimated effect size (Cohen ’s d) of 0.5. Given the 50-percent response rate, the current study tests whether there are behavioral, cognitive, or EEG characteristics that are associated with ADHD symptom reduction and are predictors of positive response to TNS treatment. (Source: Journal of the American Academy of Child and Adolescent Psychiatry)
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Sandra K. Loo, James J. McGough Source Type: research

15.2 utilizing an event-related potential biomarker to measure the effects of brief, targeted executive function training for children with asd
ASD is associated with lifelong impairments in executive function (EF), even in the absence of intellectual disability. An emerging literature describes approaches to training EF skills among typically developing children. In these training studies, electrophysiology provides a tool for probing aspects of EF not captured by overt behavioral responses, such as response preparation, monitoring, and inhibition. The N2 ERP component is linked to conflict monitoring, distinguishes children with ASD from control subjects, and relates to behavioral inhibition and interference suppression among children with ASD. (Source: Journal ...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Susan Faja Source Type: research

15.3 electrophysiological changes following a blinded randomized controlled trial of a social competence intervention for youth with asd
Group-based social skills interventions are the most widely used treatment approach for social deficits among youth with ASD. One such intervention, sociodramatic affective-relational intervention (SDARI), is designed to offer an “enriched social environment,” whereby observed changes in social behavior are driven by repeated opportunities for motivated engagement with social contexts. In turn, these changes alter social perceptual mechanisms underlying such behavior. Although SDARI’s effects on behavior are well-estab lished, direct effects on target neural mechanisms and demographic moderators thereof a...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Erin Kang, Cara Keifer, Tessa Clarkson, Matthew Lerner Source Type: research

15.4 identifying social brain biomarkers for clinical trials in asd
ASD is a disorder reflecting significant and persistent deficits in social communication and restricted/repetitive behaviors. Early red flags for ASD are related to aspects of attention to the faces of social partners. The biomarkers of social processing are needed, because they represent objective indicators of social brain processes and may identify the altered circuitry that underlies social impairment. Several EEG variables show sensitization for social information: the Nc and N170 components are larger and faster to socially relevant information; and increased theta power/decreased alpha power reflects greater cortica...
Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 1, 2019 Category: Psychiatry Authors: Sara J. Webb Source Type: research